Re:Oxford-AstraZeneca coronavirus vaccine approved for use i...
by BillyTheKing on Wednesday December 30, 2020 @04:56AM
(#25580260)
that 62% number is for symptomatic cases, I think it was around 50% for asymptomatic cases - the different efficacy-rates are fairly comparable
[ Parent
| on HN ]
Re:Oxford-AstraZeneca coronavirus vaccine approved for use i...
by emn13 on Wednesday December 30, 2020 @05:06AM
(#25580318)
That is a good point, I'd forgotten that bit ;-).
(ref: https://www.thelancet.com/journals/lancet/article/PIIS0140-6... vs. e.g. https://www.nejm.org/doi/full/10.1056/NEJMoa2034577 )